Record Leasing Volume and Positive Absorption
Signed 218 office leases totaling 909,000 sq ft in Q1, including a single-quarter record of 461,000 sq ft of new leases and 448,000 sq ft of renewals; approximately 100,000 sq ft of positive absorption for the second consecutive quarter.
Large-Tenant Leasing Strength
Record leasing to tenants >10,000 sq ft (most ever), with numerous deals between 10k–20k sq ft and several >20k sq ft, reflecting broader industry demand and diversification across legal, financial services, entertainment, real estate, and accounting.
Improved Lease Economics (Straight-Line)
Overall straight-line value of new leases increased by 5.3% in the quarter, indicating improving long-term lease economics.
Residential Portfolio Outperformance
Residential cash same-property NOI rose 4.2% year-over-year and the residential portfolio remains over 99% leased.
Successful Strategic Acquisition — Bedford Collection
JV acquisition of the Bedford medical office portfolio (five buildings, ~246k sq ft) for ~$260 million (~high $900s–$1,000 per sq ft); Douglas Emmett holds a 13% stake in the JV's $150M equity; JV debt structured with $130M nonrecourse loan (SOFR +170 bps), effectively fixed at 5.26% through April 2030.
Portfolio Concentration and Operational Synergies
Company now controls roughly ~30% (one-third) of Class A office space in Beverly Hills, enabling operating synergies—recent acquisitions lowered operating expenses on average ~20% through consolidation and shared services—and lower-than-peer leasing costs (average leasing costs $6.30 psf/yr).
Progress on Redevelopment & Mixed-Use Projects
Studio Plaza redevelopment completed with leasing underway and some tenant move-ins; redevelopment of the 712-unit Landmark Residences continues; plan to commence conversion of 10900 Wilshire to 323 apartments this year.
Capital Markets and Cost of Debt Improvements
Management has extended debt at relatively attractive rates vs. the broader market (example: Bedford JV effectively fixed at 5.26%); G&A remains low at ~5.4% of revenue—stated as the lowest among benchmark peers.